XTR008 significantly improved PFS, ORR, and quality of life compared to octreotide LAR in SSTR-positive GEP-NETs. XTR008 therapy shows significant benefits in treating GEP-NETs, enhancing survival ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈